About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

150 MG double-blinded secukinumab
(D09967)

-

-

-

-

[1] 271 💬

2

150 MG OPEN-label secukinumab
(D09967)

-

-

-

-

[1] 271 💬

3

300 MG double-blinded secukinumab
(D09967)

-

-

-

-

[1] 271 💬

4

Secukinumab
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[8] 13, 37, 41, 46, 107, 160, 269, 271 💬

Disease ID	Name
13	Multiple sclerosis
37	Generalised pustular psoriasis
41	Giant cell arteritis
46	Malignant rheumatoid arthritis
107	Juvenile idiopathic arthritis
160	Congenital ichthyosis
269	Pyogenic arthritis
271	Ankylosing spondylitis

5

Secukinumab 150 MG
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 41 💬

6

Secukinumab 150 MG (2 injections PER dose
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 269 💬

7

Secukinumab 150 MG/1 ML solution FOR injection
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[2] 37, 271 💬

8

Secukinumab 150 MG/ML
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 271 💬

9

Secukinumab 150MG
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 37 💬

10

Secukinumab 300 MG
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 41 💬

11

Secukinumab 300MG
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 37 💬

12

Secukinumab 75 MG/0.5 ML solution FOR injection
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 271 💬

13

Secukinumab injection
(D09967)

[1] Secukinumab

[1] Secukinumab (D09967) 💬

[1] IL17A 💬

[6] Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬

[1] 160 💬